Monitoring clinical trials. Interim data should not be publicly available.

Monitoring clinical trials. Interim data should not be publicly available.

Dades bibliogràfiques
Autor principal:	Richards, S
Format:	Journal article
Idioma:	English
Publicat:	2001

Ítems similars

Issues in data monitoring and interim analysis of trials.
per: Grant, A, et al.
Publicat: (2005)

Issues in data monitoring and interim analysis of trials
per: A Grant, et al.
Publicat: (2005-03-01)

Interim monitoring of clinical trials: Decision theory, dynamic programming and optimal stopping
per: CHRISTOPHER JENNISON, et al.
Publicat: (2013-09-01)

Interim data monitoring to enroll higher-risk participants in HIV prevention trials
per: Umo-Otong John, et al.
Publicat: (2009-06-01)

Guidance on interim analysis methods in clinical trials
per: Jody D. Ciolino, et al.
Publicat: (2023-01-01)

Authors should make their data available.
per: Altman, D, et al.
Publicat: (2001)

Results availability and timeliness of registered COVID-19 clinical trials: interim cross-sectional results from the DIRECCT study
per: Salholz-Hillel, M, et al.
Publicat: (2021)

Results availability and timeliness of registered COVID-19 clinical trials: interim cross-sectional results from the DIRECCT study
per: Daniel Strech, et al.
Publicat: (2021-11-01)

Decision on performing interim analysis for comparative clinical trials
per: Kyongsun Pak, et al.
Publicat: (2017-09-01)

A comparative analysis of important public clinical trial registries, and a proposal for an interim ideal one.
per: Nisha Venugopal, et al.
Publicat: (2021-01-01)

Sharing some interim data in trial monitoring can mislead or unmask trial investigators: A scenario-based survey of trial experts
per: Victoria Borg Debono, et al.
Publicat: (2017-09-01)

Use of Accelerometer Activity Monitors to Detect Changes in Pruritic Behaviors: Interim Clinical Data on 6 Dogs
per: Susan M. Wernimont, et al.
Publicat: (2018-01-01)

The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias
per: Hampton John, et al.
Publicat: (2008-03-01)

Decision making in clinical trials: Interim analyses, innovative design, and biomarkers
per: Kathleen A. Welsh‐Bohmer, et al.
Publicat: (2023-10-01)

Interim analysis: A rational approach of decision making in clinical trial
per: Amal Kumar, et al.
Publicat: (2016-01-01)

Approaches to interim analysis of cancer randomised clinical trials with time to event endpoints: A survey from the Italian National Monitoring Centre for Clinical Trials
per: De Rosa Marisa, et al.
Publicat: (2008-07-01)

Estimation and Monitoring of COVID-19's Transmissibility From Publicly Available Data
per: Antonio Silveira, et al.
Publicat: (2020-11-01)

Interim clinical trial analysis of intraoperative mass spectrometry for breast cancer surgery
per: Sankha S. Basu, et al.
Publicat: (2021-09-01)

CANparent trial evaluation: First interim report
per: Cullen, M, et al.
Publicat: (2013)

CANparent trial evaluation: second interim report
per: Cullen, M, et al.
Publicat: (2014)

Availability of junk food should be reduced.
per: Tammam, J, et al.
Publicat: (2012)

Interim Report of the LOGO Project in the Brookline Public Schools
per: Members of the LOGO Project
Publicat: (2004)

Completeness of reporting of patient-relevant clinical trial outcomes: comparison of unpublished clinical study reports with publicly available data.
per: Beate Wieseler, et al.
Publicat: (2013-10-01)

Interim analyses of data as they accumulate in laboratory experimentation
per: Ludbrook John
Publicat: (2003-08-01)

Registration quality and availability of publications for clinical trials in Germany and the influence of structural factors.
per: Christian Thiele, et al.
Publicat: (2022-01-01)

Scoping review and characteristics of publicly available checklists for assessing clinical trial feasibility
per: Viktoria Gloy, et al.
Publicat: (2022-05-01)

Registration quality and availability of publications for clinical trials in Germany and the influence of structural factors
per: Christian Thiele, et al.
Publicat: (2022-01-01)

Should the impact factor of the year of publication or the last available one be used when evaluating scientists?
per: Gustavo A. Slafer, et al.
Publicat: (2020-12-01)

Laporan interim /
per: Universiti Teknologi Malaysia. Unit Penyelidikan dan Perundingan
Publicat: (1993)

Partnering with social service staff to implement pragmatic clinical trials: an interim analysis of implementation strategies
per: Lisa A. Juckett, et al.
Publicat: (2023-11-01)

Should data from demographic surveillance systems be made more widely available to researchers?
per: Chandramohan, D, et al.
Publicat: (2008)

Should data from demographic surveillance systems be made more widely available to researchers?
per: Chandramohan, D, et al.
Publicat: (2008)

Health data on public trial: To what extent should patients control access to patient records?
per: Malcolm Oswald, et al.
Publicat: (2017-04-01)

Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
per: Akram Al-Ibraheem, et al.
Publicat: (2022-10-01)

A randomised clinical trial of intrapartum fetal monitoring with computer analysis and alerts versus previously available monitoring
per: Santos Cristina, et al.
Publicat: (2010-10-01)

How large should a clinical trial be?
per: Pezeshk, H, et al.
Publicat: (2000)

PRISONS AND HEALTH Availability of junk food should be reduced
per: Tammam, J, et al.
Publicat: (2012)

Direct current cardioversion during pregnancy should be performed with facilities available for fetal monitoring and emergency caesarean section.
per: Barnes, E, et al.
Publicat: (2002)

Interim financial reporting
per: 6724 Lembaga Piawaian Perakaunan Malaysia
Publicat: (2001)

Prodigy Interim Report
per: Ian Purves, et al.
Publicat: (1996-09-01)